Expression of the histone methyltransferase EZH2 in colorectal cancer

被引：0

作者：

Carvalho, S. Dias ^{[1
]}

Monteiro-Reis, S. ^{[1
]}

Vieira-Coimbra, M. ^{[1
]}

Pires-Luis, A. ^{[1
]}

Tavares, A. ^{[1
]}

Santos, L. L. ^{[1
]}

Raimundo, A. ^{[1
]}

Jeronimo, C. ^{[1
]}

Henrique, R. ^{[1
]}

机构：

[1] Portuguese Oncol Inst, Oporto, Portugal

来源：

VIRCHOWS ARCHIV | 2016年 / 469卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

OFP-01-013

引用

页码：S4 / S4

页数：1

共 50 条

[41] Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, Sooryanarayana
Cao, Qi
Mani, Ram-Shankar
Shankar, Sunita
Wang, Xiaosong
Ateeq, Bushra
Laxman, Bharathi
Cao, Xuhong
Jing, Xiaojun
Ramnarayanan, Kalpana
Brenner, J. Chad
Yu, Jindan
Kim, Jung H.
Han, Bo
Tan, Patrick
Kumar-Sinha, Chandan
Lonigro, Robert J.
Palanisamy, Nallasivam
Maher, Christopher A.
Chinnaiyan, Arul M.
SCIENCE, 2008, 322 (5908) : 1695 - 1699
[42] CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
Sergey Karakashev
Hengrui Zhu
Shuai Wu
Yuhki Yokoyama
Benjamin G. Bitler
Pyoung-Hwa Park
Jeong-Heon Lee
Andrew V. Kossenkov
Krutika Satish Gaonkar
Huihuang Yan
Ronny Drapkin
Jose R. Conejo-Garcia
David W. Speicher
Tamas Ordog
Rugang Zhang
Nature Communications, 9
[43] Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
Oki, Shinya
Sone, Kenbun
Oda, Katsutoshi
Hamamoto, Ryuji
Ikemura, Masako
Maeda, Daichi
Takeuchi, Makoto
Tanikawa, Michihiro
Mori-Uchino, Mayuyo
Nagasaka, Kazunori
Miyasaka, Aki
Kashiyama, Tomoko
Ikeda, Yuji
Arimoto, Takahide
Kuramoto, Hiroyuki
Wada-Hiraike, Osamu
Kawana, Kei
Fukayama, Masashi
Osuga, Yutaka
Fujii, Tomoyuki
ONCOTARGET, 2017, 8 (25) : 40402 - 40411
[44] CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
Karakashev, Sergey
Zhu, Hengrui
Wu, Shuai
Yokoyama, Yuhki
Bitler, Benjamin G.
Park, Pyoung-Hwa
Lee, Jeong-Heon
Kossenkov, Andrew V.
Gaonkar, Krutika Satish
Yan, Huihuang
Drapkin, Ronny
Conejo-Garcia, Jose R.
Speicher, David W.
Ordog, Tamas
Zhang, Rugang
NATURE COMMUNICATIONS, 2018, 9
[45] The change of EZH2 expression in development of colorectal cancer from adenoma
Ohuchi, Mayuko
Nakamoto, Yasuo
Tokunaga, Ryuma
Nakamura, Kenichi
Kosumi, Keisuke
Harada, Kazuto
Shigaki, Hironobu
Kurashige, Junji
Iwatsuki, Masaaki
Baba, Yoshifumi
Miyamoto, Yuji
Yoshida, Naoya
Baba, Hideo
CANCER RESEARCH, 2016, 76
[46] Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia
Yang, Xiaoyang
Wan, Mengjie
Yu, Feng
Wu, Xiuji
CELLULAR SIGNALLING, 2021, 87
[47] HISTONE METHYLTRANSFERASE EZH2 IS CRITICAL FOR HSD11B2 EXPRESSION IN HUMAN TROPHOBLAST CELLS
Zuo, Rujuan
Liu, Xiaohui
Lu, Yi
Li, Wenjiao
Sun, Kang
PLACENTA, 2016, 45 : 101 - 101
[48] The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors
Svedlund, Jessica
Barazeghi, Elham
Stalberg, Peter
Hellman, Per
Akerstrom, Goran
Bjorklund, Peyman
Westin, Gunnar
ENDOCRINE-RELATED CANCER, 2014, 21 (02) : 231 - 239
[49] Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
Jie Zhou
Shuo Huang
Zhongyu Wang
Jiani Huang
Liang Xu
Xuefeng Tang
Yisong Y. Wan
Qi-jing Li
Alistair L. J. Symonds
Haixia Long
Bo Zhu
Nature Communications, 10
[50] The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Zingg, Daniel
Arenas-Ramirez, Natalia
Sahin, Dilara
Rosalia, Rodney A.
Antunes, Ana T.
Haeusel, Jessica
Sommer, Lukas
Boyman, Onur
CELL REPORTS, 2017, 20 (04): : 854 - 867

← 1 2 3 4 5 →